GlaxoSmithKline plc (GSK Plc.): Clinical trial results for mocertatug rezetecan (Mo-Rez), a drug for ovarian cancer, are leaning positiveWallstreetcn·Apr 12 at 02:40 PMGSKIBB+1.27%
GlaxoSmithKline plc: The registration application for the RSV vaccine Arexvy has been accepted in China, and approval is expected in 2027Wallstreetcn·Feb 10 at 08:57 AMGSK+1.71%GSK
